Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Gitto

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Cells|October 23, 2021
Cellular and Molecular Mechanisms Underlying Liver Fibrosis RegressionAlessandra Caligiuri, Alessandra Gentilini, Mirella Pastore, et al.
Internal and Emergency Medicine|February 7, 2021
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liverStefano Gitto, Claudia Campani, Sergio Generini, et al.
Cancers|July 27, 2022
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCCLuca Marzi, Andrea Mega, Stefano Gitto, et al.
Hepatobiliary Surgery and Nutrition|August 25, 2020
Hepatocellular carcinoma and liver transplant: beyond the Milan criteria and the risk of "short-blanket" syndromeStefano Gitto, Stefano Di Sandro, Paolo Magistri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 4, 2016
Non-alcoholic steatohepatitis and liver transplantationStefano Gitto, Ranka Vukotic, Giovanni Vitale, et al.
International Journal of Molecular Sciences|November 9, 2024
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the LiverLuca Marzi, Andrea Mega, Chiara Turri, et al.
Cancers|September 9, 2022
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver CancerAlessandra Caligiuri, Stefano Gitto, Giulia Lori, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Side Effects of Immunosuppressant Drugs After Liver TransplantFilippo Gabrielli, Elisa Bernasconi, Arianna Toscano, et al.
Journal of Clinical Medicine|August 10, 2024
Frailty after Liver Transplantation: A Complex Unexplored IssueFilippo Gabrielli, Filippo Biagi, Alessandra Avossa, et al.
Viruses|July 27, 2022
Virological Treatment Monitoring for Chronic Hepatitis BElisabetta Loggi, Stefano Gitto, Filippo Gabrielli, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Cells|October 23, 2021
Cellular and Molecular Mechanisms Underlying Liver Fibrosis RegressionAlessandra Caligiuri, Alessandra Gentilini, Mirella Pastore, et al.
Internal and Emergency Medicine|February 7, 2021
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liverStefano Gitto, Claudia Campani, Sergio Generini, et al.
Cancers|July 27, 2022
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCCLuca Marzi, Andrea Mega, Stefano Gitto, et al.
Hepatobiliary Surgery and Nutrition|August 25, 2020
Hepatocellular carcinoma and liver transplant: beyond the Milan criteria and the risk of "short-blanket" syndromeStefano Gitto, Stefano Di Sandro, Paolo Magistri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 4, 2016
Non-alcoholic steatohepatitis and liver transplantationStefano Gitto, Ranka Vukotic, Giovanni Vitale, et al.
International Journal of Molecular Sciences|November 9, 2024
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the LiverLuca Marzi, Andrea Mega, Chiara Turri, et al.
Cancers|September 9, 2022
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver CancerAlessandra Caligiuri, Stefano Gitto, Giulia Lori, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Side Effects of Immunosuppressant Drugs After Liver TransplantFilippo Gabrielli, Elisa Bernasconi, Arianna Toscano, et al.
Journal of Clinical Medicine|August 10, 2024
Frailty after Liver Transplantation: A Complex Unexplored IssueFilippo Gabrielli, Filippo Biagi, Alessandra Avossa, et al.
Viruses|July 27, 2022
Virological Treatment Monitoring for Chronic Hepatitis BElisabetta Loggi, Stefano Gitto, Filippo Gabrielli, et al.
Pageof 10